nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CHRM3—muscle of abdomen—stomach cancer	0.0121	0.539	CbGeAlD
Dicyclomine—CHRM3—smooth muscle tissue—stomach cancer	0.00139	0.0618	CbGeAlD
Dicyclomine—Constipation—Irinotecan—stomach cancer	0.00127	0.00175	CcSEcCtD
Dicyclomine—Dyspnoea—Fluorouracil—stomach cancer	0.00127	0.00174	CcSEcCtD
Dicyclomine—Mental disorder—Docetaxel—stomach cancer	0.00127	0.00174	CcSEcCtD
Dicyclomine—Somnolence—Fluorouracil—stomach cancer	0.00126	0.00174	CcSEcCtD
Dicyclomine—Immune system disorder—Capecitabine—stomach cancer	0.00126	0.00174	CcSEcCtD
Dicyclomine—Mediastinal disorder—Capecitabine—stomach cancer	0.00126	0.00173	CcSEcCtD
Dicyclomine—Face oedema—Doxorubicin—stomach cancer	0.00126	0.00173	CcSEcCtD
Dicyclomine—Erythema—Docetaxel—stomach cancer	0.00126	0.00173	CcSEcCtD
Dicyclomine—Dyspepsia—Fluorouracil—stomach cancer	0.00125	0.00172	CcSEcCtD
Dicyclomine—Muscular weakness—Epirubicin—stomach cancer	0.00124	0.00171	CcSEcCtD
Dicyclomine—Decreased appetite—Fluorouracil—stomach cancer	0.00124	0.0017	CcSEcCtD
Dicyclomine—Mood swings—Doxorubicin—stomach cancer	0.00123	0.0017	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00123	0.00169	CcSEcCtD
Dicyclomine—Abdominal distension—Epirubicin—stomach cancer	0.00123	0.00168	CcSEcCtD
Dicyclomine—Mental disorder—Capecitabine—stomach cancer	0.00123	0.00168	CcSEcCtD
Dicyclomine—Feeling abnormal—Irinotecan—stomach cancer	0.00122	0.00168	CcSEcCtD
Dicyclomine—Erythema—Capecitabine—stomach cancer	0.00122	0.00167	CcSEcCtD
Dicyclomine—Pain—Fluorouracil—stomach cancer	0.00122	0.00167	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Irinotecan—stomach cancer	0.00121	0.00167	CcSEcCtD
Dicyclomine—Erectile dysfunction—Methotrexate—stomach cancer	0.0012	0.00165	CcSEcCtD
Dicyclomine—CYP1A1—hematopoietic system—stomach cancer	0.00118	0.0526	CbGeAlD
Dicyclomine—Breast disorder—Doxorubicin—stomach cancer	0.00118	0.00162	CcSEcCtD
Dicyclomine—Abdominal pain—Irinotecan—stomach cancer	0.00117	0.00161	CcSEcCtD
Dicyclomine—Feeling abnormal—Fluorouracil—stomach cancer	0.00117	0.00161	CcSEcCtD
Dicyclomine—Drowsiness—Methotrexate—stomach cancer	0.00116	0.00159	CcSEcCtD
Dicyclomine—Muscular weakness—Doxorubicin—stomach cancer	0.00115	0.00158	CcSEcCtD
Dicyclomine—Vision blurred—Capecitabine—stomach cancer	0.00115	0.00158	CcSEcCtD
Dicyclomine—Abdominal distension—Doxorubicin—stomach cancer	0.00113	0.00156	CcSEcCtD
Dicyclomine—Ill-defined disorder—Capecitabine—stomach cancer	0.00113	0.00155	CcSEcCtD
Dicyclomine—Urticaria—Fluorouracil—stomach cancer	0.00113	0.00155	CcSEcCtD
Dicyclomine—Syncope—Docetaxel—stomach cancer	0.00113	0.00155	CcSEcCtD
Dicyclomine—CHRM2—endocrine gland—stomach cancer	0.00111	0.0495	CbGeAlD
Dicyclomine—Palpitations—Docetaxel—stomach cancer	0.00111	0.00153	CcSEcCtD
Dicyclomine—Loss of consciousness—Docetaxel—stomach cancer	0.00111	0.00152	CcSEcCtD
Dicyclomine—CHRM3—digestive system—stomach cancer	0.0011	0.0488	CbGeAlD
Dicyclomine—Malaise—Capecitabine—stomach cancer	0.0011	0.00151	CcSEcCtD
Dicyclomine—Hypersensitivity—Irinotecan—stomach cancer	0.00109	0.0015	CcSEcCtD
Dicyclomine—Syncope—Capecitabine—stomach cancer	0.00109	0.0015	CcSEcCtD
Dicyclomine—Hypertension—Docetaxel—stomach cancer	0.00109	0.00149	CcSEcCtD
Dicyclomine—Drowsiness—Epirubicin—stomach cancer	0.00109	0.00149	CcSEcCtD
Dicyclomine—CYP1A1—epithelium—stomach cancer	0.00108	0.048	CbGeAlD
Dicyclomine—Palpitations—Capecitabine—stomach cancer	0.00108	0.00148	CcSEcCtD
Dicyclomine—Loss of consciousness—Capecitabine—stomach cancer	0.00107	0.00147	CcSEcCtD
Dicyclomine—Asthenia—Irinotecan—stomach cancer	0.00107	0.00146	CcSEcCtD
Dicyclomine—Hypertension—Capecitabine—stomach cancer	0.00105	0.00144	CcSEcCtD
Dicyclomine—Hypersensitivity—Fluorouracil—stomach cancer	0.00105	0.00144	CcSEcCtD
Dicyclomine—Dry mouth—Docetaxel—stomach cancer	0.00105	0.00144	CcSEcCtD
Dicyclomine—Confusional state—Docetaxel—stomach cancer	0.00103	0.00142	CcSEcCtD
Dicyclomine—Anaphylactic shock—Docetaxel—stomach cancer	0.00103	0.00141	CcSEcCtD
Dicyclomine—Oedema—Docetaxel—stomach cancer	0.00103	0.00141	CcSEcCtD
Dicyclomine—Discomfort—Capecitabine—stomach cancer	0.00102	0.00141	CcSEcCtD
Dicyclomine—CHRM1—endocrine gland—stomach cancer	0.00101	0.0451	CbGeAlD
Dicyclomine—Dry mouth—Capecitabine—stomach cancer	0.00101	0.00139	CcSEcCtD
Dicyclomine—Shock—Docetaxel—stomach cancer	0.00101	0.00139	CcSEcCtD
Dicyclomine—Nervous system disorder—Docetaxel—stomach cancer	0.00101	0.00138	CcSEcCtD
Dicyclomine—Pruritus—Fluorouracil—stomach cancer	0.00101	0.00138	CcSEcCtD
Dicyclomine—Drowsiness—Doxorubicin—stomach cancer	0.001	0.00138	CcSEcCtD
Dicyclomine—Confusional state—Capecitabine—stomach cancer	0.001	0.00138	CcSEcCtD
Dicyclomine—Tachycardia—Docetaxel—stomach cancer	0.001	0.00138	CcSEcCtD
Dicyclomine—Oedema—Capecitabine—stomach cancer	0.000994	0.00137	CcSEcCtD
Dicyclomine—Dizziness—Irinotecan—stomach cancer	0.000982	0.00135	CcSEcCtD
Dicyclomine—Anorexia—Docetaxel—stomach cancer	0.000978	0.00134	CcSEcCtD
Dicyclomine—Shock—Capecitabine—stomach cancer	0.000978	0.00134	CcSEcCtD
Dicyclomine—Nervous system disorder—Capecitabine—stomach cancer	0.000975	0.00134	CcSEcCtD
Dicyclomine—Eye disorder—Methotrexate—stomach cancer	0.000973	0.00134	CcSEcCtD
Dicyclomine—Tachycardia—Capecitabine—stomach cancer	0.00097	0.00133	CcSEcCtD
Dicyclomine—Hypoaesthesia—Epirubicin—stomach cancer	0.00097	0.00133	CcSEcCtD
Dicyclomine—Cardiac disorder—Methotrexate—stomach cancer	0.000966	0.00133	CcSEcCtD
Dicyclomine—Anorexia—Capecitabine—stomach cancer	0.000947	0.0013	CcSEcCtD
Dicyclomine—Vomiting—Irinotecan—stomach cancer	0.000944	0.0013	CcSEcCtD
Dicyclomine—Immune system disorder—Methotrexate—stomach cancer	0.000941	0.00129	CcSEcCtD
Dicyclomine—Dizziness—Fluorouracil—stomach cancer	0.00094	0.00129	CcSEcCtD
Dicyclomine—Mediastinal disorder—Methotrexate—stomach cancer	0.000938	0.00129	CcSEcCtD
Dicyclomine—Rash—Irinotecan—stomach cancer	0.000936	0.00129	CcSEcCtD
Dicyclomine—Dermatitis—Irinotecan—stomach cancer	0.000935	0.00129	CcSEcCtD
Dicyclomine—Headache—Irinotecan—stomach cancer	0.00093	0.00128	CcSEcCtD
Dicyclomine—Insomnia—Docetaxel—stomach cancer	0.000928	0.00128	CcSEcCtD
Dicyclomine—Paraesthesia—Docetaxel—stomach cancer	0.000922	0.00127	CcSEcCtD
Dicyclomine—Dyspnoea—Docetaxel—stomach cancer	0.000915	0.00126	CcSEcCtD
Dicyclomine—Somnolence—Docetaxel—stomach cancer	0.000912	0.00125	CcSEcCtD
Dicyclomine—Mental disorder—Methotrexate—stomach cancer	0.000912	0.00125	CcSEcCtD
Dicyclomine—Eye disorder—Epirubicin—stomach cancer	0.000911	0.00125	CcSEcCtD
Dicyclomine—CHRM3—endocrine gland—stomach cancer	0.000908	0.0403	CbGeAlD
Dicyclomine—Erythema—Methotrexate—stomach cancer	0.000906	0.00125	CcSEcCtD
Dicyclomine—Cardiac disorder—Epirubicin—stomach cancer	0.000904	0.00124	CcSEcCtD
Dicyclomine—Vomiting—Fluorouracil—stomach cancer	0.000904	0.00124	CcSEcCtD
Dicyclomine—Dyspepsia—Docetaxel—stomach cancer	0.000904	0.00124	CcSEcCtD
Dicyclomine—Insomnia—Capecitabine—stomach cancer	0.000899	0.00124	CcSEcCtD
Dicyclomine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000897	0.00123	CcSEcCtD
Dicyclomine—Rash—Fluorouracil—stomach cancer	0.000897	0.00123	CcSEcCtD
Dicyclomine—Dermatitis—Fluorouracil—stomach cancer	0.000896	0.00123	CcSEcCtD
Dicyclomine—Paraesthesia—Capecitabine—stomach cancer	0.000892	0.00123	CcSEcCtD
Dicyclomine—Decreased appetite—Docetaxel—stomach cancer	0.000892	0.00123	CcSEcCtD
Dicyclomine—Headache—Fluorouracil—stomach cancer	0.000891	0.00122	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000886	0.00122	CcSEcCtD
Dicyclomine—Dyspnoea—Capecitabine—stomach cancer	0.000886	0.00122	CcSEcCtD
Dicyclomine—Fatigue—Docetaxel—stomach cancer	0.000885	0.00122	CcSEcCtD
Dicyclomine—Nausea—Irinotecan—stomach cancer	0.000882	0.00121	CcSEcCtD
Dicyclomine—Immune system disorder—Epirubicin—stomach cancer	0.00088	0.00121	CcSEcCtD
Dicyclomine—Mediastinal disorder—Epirubicin—stomach cancer	0.000878	0.00121	CcSEcCtD
Dicyclomine—Pain—Docetaxel—stomach cancer	0.000878	0.00121	CcSEcCtD
Dicyclomine—Constipation—Docetaxel—stomach cancer	0.000878	0.00121	CcSEcCtD
Dicyclomine—Dyspepsia—Capecitabine—stomach cancer	0.000875	0.0012	CcSEcCtD
Dicyclomine—Decreased appetite—Capecitabine—stomach cancer	0.000864	0.00119	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000858	0.00118	CcSEcCtD
Dicyclomine—Fatigue—Capecitabine—stomach cancer	0.000857	0.00118	CcSEcCtD
Dicyclomine—Vision blurred—Methotrexate—stomach cancer	0.000854	0.00117	CcSEcCtD
Dicyclomine—Mental disorder—Epirubicin—stomach cancer	0.000854	0.00117	CcSEcCtD
Dicyclomine—Constipation—Capecitabine—stomach cancer	0.00085	0.00117	CcSEcCtD
Dicyclomine—Pain—Capecitabine—stomach cancer	0.00085	0.00117	CcSEcCtD
Dicyclomine—Erythema—Epirubicin—stomach cancer	0.000848	0.00117	CcSEcCtD
Dicyclomine—Feeling abnormal—Docetaxel—stomach cancer	0.000846	0.00116	CcSEcCtD
Dicyclomine—Nausea—Fluorouracil—stomach cancer	0.000845	0.00116	CcSEcCtD
Dicyclomine—Eye disorder—Doxorubicin—stomach cancer	0.000843	0.00116	CcSEcCtD
Dicyclomine—Ill-defined disorder—Methotrexate—stomach cancer	0.000841	0.00116	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000839	0.00115	CcSEcCtD
Dicyclomine—Cardiac disorder—Doxorubicin—stomach cancer	0.000837	0.00115	CcSEcCtD
Dicyclomine—Tension—Epirubicin—stomach cancer	0.000832	0.00114	CcSEcCtD
Dicyclomine—Nervousness—Epirubicin—stomach cancer	0.000824	0.00113	CcSEcCtD
Dicyclomine—CYP1A1—digestive system—stomach cancer	0.000823	0.0365	CbGeAlD
Dicyclomine—Feeling abnormal—Capecitabine—stomach cancer	0.000819	0.00113	CcSEcCtD
Dicyclomine—Malaise—Methotrexate—stomach cancer	0.000817	0.00112	CcSEcCtD
Dicyclomine—Immune system disorder—Doxorubicin—stomach cancer	0.000814	0.00112	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000813	0.00112	CcSEcCtD
Dicyclomine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000813	0.00112	CcSEcCtD
Dicyclomine—Abdominal pain—Docetaxel—stomach cancer	0.000811	0.00112	CcSEcCtD
Dicyclomine—Vision blurred—Epirubicin—stomach cancer	0.000799	0.0011	CcSEcCtD
Dicyclomine—Mental disorder—Doxorubicin—stomach cancer	0.00079	0.00109	CcSEcCtD
Dicyclomine—Urticaria—Capecitabine—stomach cancer	0.000789	0.00109	CcSEcCtD
Dicyclomine—Ill-defined disorder—Epirubicin—stomach cancer	0.000787	0.00108	CcSEcCtD
Dicyclomine—Abdominal pain—Capecitabine—stomach cancer	0.000786	0.00108	CcSEcCtD
Dicyclomine—Erythema—Doxorubicin—stomach cancer	0.000785	0.00108	CcSEcCtD
Dicyclomine—Agitation—Epirubicin—stomach cancer	0.00078	0.00107	CcSEcCtD
Dicyclomine—Tension—Doxorubicin—stomach cancer	0.00077	0.00106	CcSEcCtD
Dicyclomine—Malaise—Epirubicin—stomach cancer	0.000765	0.00105	CcSEcCtD
Dicyclomine—Discomfort—Methotrexate—stomach cancer	0.000762	0.00105	CcSEcCtD
Dicyclomine—Nervousness—Doxorubicin—stomach cancer	0.000762	0.00105	CcSEcCtD
Dicyclomine—Syncope—Epirubicin—stomach cancer	0.000761	0.00105	CcSEcCtD
Dicyclomine—Hypersensitivity—Docetaxel—stomach cancer	0.000756	0.00104	CcSEcCtD
Dicyclomine—Palpitations—Epirubicin—stomach cancer	0.00075	0.00103	CcSEcCtD
Dicyclomine—Confusional state—Methotrexate—stomach cancer	0.000746	0.00103	CcSEcCtD
Dicyclomine—Loss of consciousness—Epirubicin—stomach cancer	0.000746	0.00102	CcSEcCtD
Dicyclomine—Anaphylactic shock—Methotrexate—stomach cancer	0.00074	0.00102	CcSEcCtD
Dicyclomine—Vision blurred—Doxorubicin—stomach cancer	0.00074	0.00102	CcSEcCtD
Dicyclomine—Asthenia—Docetaxel—stomach cancer	0.000736	0.00101	CcSEcCtD
Dicyclomine—Hypertension—Epirubicin—stomach cancer	0.000732	0.00101	CcSEcCtD
Dicyclomine—Hypersensitivity—Capecitabine—stomach cancer	0.000732	0.00101	CcSEcCtD
Dicyclomine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000728	0.001	CcSEcCtD
Dicyclomine—Pruritus—Docetaxel—stomach cancer	0.000726	0.000998	CcSEcCtD
Dicyclomine—Nervous system disorder—Methotrexate—stomach cancer	0.000725	0.000997	CcSEcCtD
Dicyclomine—Agitation—Doxorubicin—stomach cancer	0.000721	0.000991	CcSEcCtD
Dicyclomine—Discomfort—Epirubicin—stomach cancer	0.000714	0.000981	CcSEcCtD
Dicyclomine—Asthenia—Capecitabine—stomach cancer	0.000713	0.00098	CcSEcCtD
Dicyclomine—Malaise—Doxorubicin—stomach cancer	0.000708	0.000973	CcSEcCtD
Dicyclomine—Dry mouth—Epirubicin—stomach cancer	0.000706	0.000971	CcSEcCtD
Dicyclomine—Anorexia—Methotrexate—stomach cancer	0.000705	0.000969	CcSEcCtD
Dicyclomine—Syncope—Doxorubicin—stomach cancer	0.000704	0.000967	CcSEcCtD
Dicyclomine—Pruritus—Capecitabine—stomach cancer	0.000703	0.000966	CcSEcCtD
Dicyclomine—Confusional state—Epirubicin—stomach cancer	0.000698	0.000959	CcSEcCtD
Dicyclomine—Palpitations—Doxorubicin—stomach cancer	0.000694	0.000953	CcSEcCtD
Dicyclomine—Oedema—Epirubicin—stomach cancer	0.000692	0.000952	CcSEcCtD
Dicyclomine—Anaphylactic shock—Epirubicin—stomach cancer	0.000692	0.000952	CcSEcCtD
Dicyclomine—Loss of consciousness—Doxorubicin—stomach cancer	0.00069	0.000948	CcSEcCtD
Dicyclomine—Shock—Epirubicin—stomach cancer	0.000681	0.000936	CcSEcCtD
Dicyclomine—CYP1A1—endocrine gland—stomach cancer	0.00068	0.0302	CbGeAlD
Dicyclomine—Nervous system disorder—Epirubicin—stomach cancer	0.000679	0.000933	CcSEcCtD
Dicyclomine—Dizziness—Docetaxel—stomach cancer	0.000679	0.000933	CcSEcCtD
Dicyclomine—Hypertension—Doxorubicin—stomach cancer	0.000678	0.000931	CcSEcCtD
Dicyclomine—Tachycardia—Epirubicin—stomach cancer	0.000676	0.000929	CcSEcCtD
Dicyclomine—Insomnia—Methotrexate—stomach cancer	0.000669	0.00092	CcSEcCtD
Dicyclomine—Paraesthesia—Methotrexate—stomach cancer	0.000664	0.000913	CcSEcCtD
Dicyclomine—Discomfort—Doxorubicin—stomach cancer	0.00066	0.000907	CcSEcCtD
Dicyclomine—Anorexia—Epirubicin—stomach cancer	0.00066	0.000907	CcSEcCtD
Dicyclomine—Dyspnoea—Methotrexate—stomach cancer	0.00066	0.000907	CcSEcCtD
Dicyclomine—Somnolence—Methotrexate—stomach cancer	0.000658	0.000904	CcSEcCtD
Dicyclomine—Dizziness—Capecitabine—stomach cancer	0.000657	0.000903	CcSEcCtD
Dicyclomine—Dry mouth—Doxorubicin—stomach cancer	0.000654	0.000898	CcSEcCtD
Dicyclomine—Vomiting—Docetaxel—stomach cancer	0.000653	0.000897	CcSEcCtD
Dicyclomine—Dyspepsia—Methotrexate—stomach cancer	0.000651	0.000895	CcSEcCtD
Dicyclomine—Rash—Docetaxel—stomach cancer	0.000647	0.00089	CcSEcCtD
Dicyclomine—Dermatitis—Docetaxel—stomach cancer	0.000647	0.000889	CcSEcCtD
Dicyclomine—Confusional state—Doxorubicin—stomach cancer	0.000646	0.000888	CcSEcCtD
Dicyclomine—Decreased appetite—Methotrexate—stomach cancer	0.000643	0.000884	CcSEcCtD
Dicyclomine—Headache—Docetaxel—stomach cancer	0.000643	0.000884	CcSEcCtD
Dicyclomine—Oedema—Doxorubicin—stomach cancer	0.000641	0.00088	CcSEcCtD
Dicyclomine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000641	0.00088	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000639	0.000878	CcSEcCtD
Dicyclomine—Fatigue—Methotrexate—stomach cancer	0.000638	0.000877	CcSEcCtD
Dicyclomine—Pain—Methotrexate—stomach cancer	0.000633	0.00087	CcSEcCtD
Dicyclomine—Vomiting—Capecitabine—stomach cancer	0.000632	0.000868	CcSEcCtD
Dicyclomine—Shock—Doxorubicin—stomach cancer	0.00063	0.000866	CcSEcCtD
Dicyclomine—Nervous system disorder—Doxorubicin—stomach cancer	0.000628	0.000863	CcSEcCtD
Dicyclomine—Rash—Capecitabine—stomach cancer	0.000627	0.000861	CcSEcCtD
Dicyclomine—Insomnia—Epirubicin—stomach cancer	0.000626	0.000861	CcSEcCtD
Dicyclomine—Dermatitis—Capecitabine—stomach cancer	0.000626	0.00086	CcSEcCtD
Dicyclomine—Tachycardia—Doxorubicin—stomach cancer	0.000625	0.000859	CcSEcCtD
Dicyclomine—Headache—Capecitabine—stomach cancer	0.000623	0.000856	CcSEcCtD
Dicyclomine—Paraesthesia—Epirubicin—stomach cancer	0.000622	0.000854	CcSEcCtD
Dicyclomine—Dyspnoea—Epirubicin—stomach cancer	0.000617	0.000848	CcSEcCtD
Dicyclomine—Somnolence—Epirubicin—stomach cancer	0.000615	0.000846	CcSEcCtD
Dicyclomine—CYP1A1—liver—stomach cancer	0.000613	0.0272	CbGeAlD
Dicyclomine—Anorexia—Doxorubicin—stomach cancer	0.000611	0.000839	CcSEcCtD
Dicyclomine—Nausea—Docetaxel—stomach cancer	0.00061	0.000838	CcSEcCtD
Dicyclomine—Feeling abnormal—Methotrexate—stomach cancer	0.00061	0.000838	CcSEcCtD
Dicyclomine—Dyspepsia—Epirubicin—stomach cancer	0.000609	0.000838	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000605	0.000831	CcSEcCtD
Dicyclomine—Decreased appetite—Epirubicin—stomach cancer	0.000602	0.000827	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000598	0.000822	CcSEcCtD
Dicyclomine—Fatigue—Epirubicin—stomach cancer	0.000597	0.00082	CcSEcCtD
Dicyclomine—Pain—Epirubicin—stomach cancer	0.000592	0.000814	CcSEcCtD
Dicyclomine—Constipation—Epirubicin—stomach cancer	0.000592	0.000814	CcSEcCtD
Dicyclomine—Nausea—Capecitabine—stomach cancer	0.00059	0.000811	CcSEcCtD
Dicyclomine—Urticaria—Methotrexate—stomach cancer	0.000588	0.000808	CcSEcCtD
Dicyclomine—Abdominal pain—Methotrexate—stomach cancer	0.000585	0.000804	CcSEcCtD
Dicyclomine—Insomnia—Doxorubicin—stomach cancer	0.000579	0.000796	CcSEcCtD
Dicyclomine—Paraesthesia—Doxorubicin—stomach cancer	0.000575	0.000791	CcSEcCtD
Dicyclomine—Dyspnoea—Doxorubicin—stomach cancer	0.000571	0.000785	CcSEcCtD
Dicyclomine—Feeling abnormal—Epirubicin—stomach cancer	0.000571	0.000784	CcSEcCtD
Dicyclomine—Somnolence—Doxorubicin—stomach cancer	0.000569	0.000783	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000566	0.000778	CcSEcCtD
Dicyclomine—Dyspepsia—Doxorubicin—stomach cancer	0.000564	0.000775	CcSEcCtD
Dicyclomine—Decreased appetite—Doxorubicin—stomach cancer	0.000557	0.000765	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000553	0.00076	CcSEcCtD
Dicyclomine—Fatigue—Doxorubicin—stomach cancer	0.000552	0.000759	CcSEcCtD
Dicyclomine—Urticaria—Epirubicin—stomach cancer	0.00055	0.000756	CcSEcCtD
Dicyclomine—Pain—Doxorubicin—stomach cancer	0.000548	0.000753	CcSEcCtD
Dicyclomine—Constipation—Doxorubicin—stomach cancer	0.000548	0.000753	CcSEcCtD
Dicyclomine—Abdominal pain—Epirubicin—stomach cancer	0.000547	0.000752	CcSEcCtD
Dicyclomine—Hypersensitivity—Methotrexate—stomach cancer	0.000545	0.000749	CcSEcCtD
Dicyclomine—Asthenia—Methotrexate—stomach cancer	0.000531	0.00073	CcSEcCtD
Dicyclomine—Feeling abnormal—Doxorubicin—stomach cancer	0.000528	0.000726	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000524	0.00072	CcSEcCtD
Dicyclomine—Pruritus—Methotrexate—stomach cancer	0.000523	0.000719	CcSEcCtD
Dicyclomine—Hypersensitivity—Epirubicin—stomach cancer	0.00051	0.000701	CcSEcCtD
Dicyclomine—Urticaria—Doxorubicin—stomach cancer	0.000509	0.000699	CcSEcCtD
Dicyclomine—Abdominal pain—Doxorubicin—stomach cancer	0.000506	0.000696	CcSEcCtD
Dicyclomine—Asthenia—Epirubicin—stomach cancer	0.000497	0.000683	CcSEcCtD
Dicyclomine—Pruritus—Epirubicin—stomach cancer	0.00049	0.000673	CcSEcCtD
Dicyclomine—Dizziness—Methotrexate—stomach cancer	0.000489	0.000672	CcSEcCtD
Dicyclomine—Hypersensitivity—Doxorubicin—stomach cancer	0.000472	0.000649	CcSEcCtD
Dicyclomine—Vomiting—Methotrexate—stomach cancer	0.00047	0.000646	CcSEcCtD
Dicyclomine—CYP1A1—lymph node—stomach cancer	0.00047	0.0209	CbGeAlD
Dicyclomine—Rash—Methotrexate—stomach cancer	0.000466	0.000641	CcSEcCtD
Dicyclomine—Dermatitis—Methotrexate—stomach cancer	0.000466	0.000641	CcSEcCtD
Dicyclomine—Headache—Methotrexate—stomach cancer	0.000463	0.000637	CcSEcCtD
Dicyclomine—Asthenia—Doxorubicin—stomach cancer	0.00046	0.000632	CcSEcCtD
Dicyclomine—Dizziness—Epirubicin—stomach cancer	0.000458	0.000629	CcSEcCtD
Dicyclomine—Pruritus—Doxorubicin—stomach cancer	0.000453	0.000623	CcSEcCtD
Dicyclomine—Vomiting—Epirubicin—stomach cancer	0.00044	0.000605	CcSEcCtD
Dicyclomine—Nausea—Methotrexate—stomach cancer	0.000439	0.000604	CcSEcCtD
Dicyclomine—Rash—Epirubicin—stomach cancer	0.000437	0.0006	CcSEcCtD
Dicyclomine—Dermatitis—Epirubicin—stomach cancer	0.000436	0.000599	CcSEcCtD
Dicyclomine—Headache—Epirubicin—stomach cancer	0.000434	0.000596	CcSEcCtD
Dicyclomine—Dizziness—Doxorubicin—stomach cancer	0.000424	0.000582	CcSEcCtD
Dicyclomine—Nausea—Epirubicin—stomach cancer	0.000411	0.000565	CcSEcCtD
Dicyclomine—Vomiting—Doxorubicin—stomach cancer	0.000407	0.00056	CcSEcCtD
Dicyclomine—Rash—Doxorubicin—stomach cancer	0.000404	0.000555	CcSEcCtD
Dicyclomine—Dermatitis—Doxorubicin—stomach cancer	0.000404	0.000555	CcSEcCtD
Dicyclomine—Headache—Doxorubicin—stomach cancer	0.000401	0.000552	CcSEcCtD
Dicyclomine—Nausea—Doxorubicin—stomach cancer	0.00038	0.000523	CcSEcCtD
Dicyclomine—CHRM1—Signaling Pathways—FGG—stomach cancer	0.000106	0.000422	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGG—stomach cancer	0.000105	0.000421	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—ADRB2—stomach cancer	0.000104	0.000417	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGG—stomach cancer	0.000104	0.000417	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—ADRB2—stomach cancer	0.000104	0.000415	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—IL6—stomach cancer	0.000103	0.000412	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—ADRB2—stomach cancer	0.000103	0.000411	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000102	0.000408	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000102	0.000408	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PPP2R1A—stomach cancer	0.000102	0.000407	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTT1—stomach cancer	0.000102	0.000407	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000102	0.000407	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKAA1—stomach cancer	0.000102	0.000406	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKAA1—stomach cancer	0.000101	0.000405	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PPP2R1A—stomach cancer	0.000101	0.000403	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP2A6—stomach cancer	0.000101	0.000402	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKAA1—stomach cancer	0.0001	0.000401	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALDOB—stomach cancer	9.99e-05	0.0004	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RBP4—stomach cancer	9.81e-05	0.000392	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—CXCL8—stomach cancer	9.8e-05	0.000392	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKR1C3—stomach cancer	9.78e-05	0.000391	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RBP4—stomach cancer	9.78e-05	0.000391	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—CXCL8—stomach cancer	9.77e-05	0.000391	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	9.77e-05	0.000391	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	9.73e-05	0.000389	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RBP4—stomach cancer	9.68e-05	0.000387	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—CXCL8—stomach cancer	9.68e-05	0.000387	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ENO1—stomach cancer	9.53e-05	0.000381	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	9.42e-05	0.000377	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	9.4e-05	0.000376	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALOX5—stomach cancer	9.29e-05	0.000372	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—DPYD—stomach cancer	9.14e-05	0.000366	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CD44—stomach cancer	8.45e-05	0.000338	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HSPB1—stomach cancer	8.43e-05	0.000337	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGTR2—stomach cancer	8.43e-05	0.000337	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HSPB1—stomach cancer	8.41e-05	0.000336	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGTR2—stomach cancer	8.41e-05	0.000336	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—BMP2—stomach cancer	8.34e-05	0.000334	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—F2R—stomach cancer	8.34e-05	0.000334	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HSPB1—stomach cancer	8.33e-05	0.000333	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGTR2—stomach cancer	8.33e-05	0.000333	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—BMP2—stomach cancer	8.31e-05	0.000333	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—F2R—stomach cancer	8.31e-05	0.000333	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.28e-05	0.000331	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—BMP2—stomach cancer	8.23e-05	0.000329	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—F2R—stomach cancer	8.23e-05	0.000329	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKR1C3—stomach cancer	8.2e-05	0.000328	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKR1C3—stomach cancer	8.18e-05	0.000327	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR1A—stomach cancer	8.12e-05	0.000325	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKR1C3—stomach cancer	8.1e-05	0.000324	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR1A—stomach cancer	8.09e-05	0.000324	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTT1—stomach cancer	8.08e-05	0.000323	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR1A—stomach cancer	8.01e-05	0.000321	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP2A6—stomach cancer	7.99e-05	0.00032	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PRKCB—stomach cancer	7.86e-05	0.000315	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ANXA1—stomach cancer	7.84e-05	0.000314	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PRKCB—stomach cancer	7.84e-05	0.000314	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ANXA1—stomach cancer	7.82e-05	0.000313	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKR1C3—stomach cancer	7.77e-05	0.000311	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PRKCB—stomach cancer	7.76e-05	0.000311	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ANXA1—stomach cancer	7.74e-05	0.00031	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRB1—stomach cancer	7.59e-05	0.000304	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ENO1—stomach cancer	7.57e-05	0.000303	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRB1—stomach cancer	7.57e-05	0.000303	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRB1—stomach cancer	7.5e-05	0.0003	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.45e-05	0.000298	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RPS6—stomach cancer	7.26e-05	0.00029	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RPS6—stomach cancer	7.23e-05	0.000289	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPP2R1A—stomach cancer	7.19e-05	0.000288	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RPS6—stomach cancer	7.16e-05	0.000287	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PRKCB—stomach cancer	7.14e-05	0.000286	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PRKCB—stomach cancer	7.12e-05	0.000285	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6ST—stomach cancer	7.11e-05	0.000285	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6ST—stomach cancer	7.09e-05	0.000284	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTP1—stomach cancer	7.05e-05	0.000282	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PRKCB—stomach cancer	7.05e-05	0.000282	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6ST—stomach cancer	7.02e-05	0.000281	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HMOX1—stomach cancer	6.95e-05	0.000278	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CD44—stomach cancer	6.72e-05	0.000269	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HBEGF—stomach cancer	6.67e-05	0.000267	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HBEGF—stomach cancer	6.65e-05	0.000266	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HBEGF—stomach cancer	6.58e-05	0.000263	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—TYMS—stomach cancer	6.55e-05	0.000262	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.52e-05	0.000261	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTM1—stomach cancer	6.48e-05	0.000259	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6R—stomach cancer	6.34e-05	0.000254	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6R—stomach cancer	6.32e-05	0.000253	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	6.31e-05	0.000252	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	6.29e-05	0.000252	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6R—stomach cancer	6.26e-05	0.000251	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	6.23e-05	0.000249	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRB2—stomach cancer	6.15e-05	0.000246	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRB2—stomach cancer	6.13e-05	0.000245	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ERCC2—stomach cancer	6.09e-05	0.000244	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRB2—stomach cancer	6.07e-05	0.000243	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	6.03e-05	0.000241	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	6.01e-05	0.000241	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	5.95e-05	0.000238	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—RHOA—stomach cancer	5.73e-05	0.000229	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—stomach cancer	5.73e-05	0.000229	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—RHOA—stomach cancer	5.71e-05	0.000229	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPP2R1A—stomach cancer	5.71e-05	0.000228	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—RHOA—stomach cancer	5.66e-05	0.000226	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTP1—stomach cancer	5.6e-05	0.000224	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SMAD4—stomach cancer	5.6e-05	0.000224	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SMAD4—stomach cancer	5.58e-05	0.000223	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	5.54e-05	0.000222	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SMAD4—stomach cancer	5.53e-05	0.000221	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—stomach cancer	5.52e-05	0.000221	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	5.52e-05	0.000221	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	5.47e-05	0.000219	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FYN—stomach cancer	5.32e-05	0.000213	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FYN—stomach cancer	5.3e-05	0.000212	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAV1—stomach cancer	5.28e-05	0.000211	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOA1—stomach cancer	5.27e-05	0.000211	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FYN—stomach cancer	5.25e-05	0.00021	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—TYMS—stomach cancer	5.21e-05	0.000208	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTM1—stomach cancer	5.15e-05	0.000206	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	5.03e-05	0.000201	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	5.01e-05	0.000201	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGFR2—stomach cancer	4.99e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGFR2—stomach cancer	4.97e-05	0.000199	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	4.97e-05	0.000199	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGFR2—stomach cancer	4.93e-05	0.000197	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ERCC2—stomach cancer	4.84e-05	0.000194	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—stomach cancer	4.64e-05	0.000186	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS2—stomach cancer	4.57e-05	0.000183	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS2—stomach cancer	4.56e-05	0.000182	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—stomach cancer	4.55e-05	0.000182	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS2—stomach cancer	4.51e-05	0.00018	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CAV1—stomach cancer	4.43e-05	0.000177	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOA1—stomach cancer	4.42e-05	0.000177	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CAV1—stomach cancer	4.42e-05	0.000177	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOA1—stomach cancer	4.41e-05	0.000176	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CAV1—stomach cancer	4.37e-05	0.000175	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOA1—stomach cancer	4.36e-05	0.000175	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCB—stomach cancer	4.22e-05	0.000169	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCB—stomach cancer	4.2e-05	0.000168	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6ST—stomach cancer	4.2e-05	0.000168	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAV1—stomach cancer	4.2e-05	0.000168	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6ST—stomach cancer	4.19e-05	0.000168	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOA1—stomach cancer	4.19e-05	0.000168	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALB—stomach cancer	4.18e-05	0.000167	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCB—stomach cancer	4.16e-05	0.000167	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6ST—stomach cancer	4.15e-05	0.000166	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APC—stomach cancer	4.04e-05	0.000161	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APC—stomach cancer	4.02e-05	0.000161	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.01e-05	0.00016	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NOS3—stomach cancer	3.99e-05	0.00016	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APC—stomach cancer	3.98e-05	0.000159	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	3.87e-05	0.000155	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	3.85e-05	0.000154	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	3.82e-05	0.000153	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6R—stomach cancer	3.75e-05	0.00015	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6R—stomach cancer	3.74e-05	0.000149	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6R—stomach cancer	3.7e-05	0.000148	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—stomach cancer	3.69e-05	0.000148	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	3.68e-05	0.000147	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EGFR—stomach cancer	3.68e-05	0.000147	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	3.67e-05	0.000147	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EGFR—stomach cancer	3.67e-05	0.000147	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—stomach cancer	3.65e-05	0.000146	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	3.63e-05	0.000145	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EGFR—stomach cancer	3.63e-05	0.000145	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	3.51e-05	0.000141	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	3.51e-05	0.00014	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	3.5e-05	0.00014	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	3.5e-05	0.00014	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—KRAS—stomach cancer	3.47e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	3.47e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	3.46e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—KRAS—stomach cancer	3.46e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—KRAS—stomach cancer	3.43e-05	0.000137	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RHOA—stomach cancer	3.39e-05	0.000135	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RHOA—stomach cancer	3.37e-05	0.000135	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOS3—stomach cancer	3.35e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RHOA—stomach cancer	3.34e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOS3—stomach cancer	3.34e-05	0.000134	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALB—stomach cancer	3.32e-05	0.000133	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOS3—stomach cancer	3.31e-05	0.000132	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	3.19e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	3.18e-05	0.000127	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NOS3—stomach cancer	3.17e-05	0.000127	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	3.15e-05	0.000126	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ERBB2—stomach cancer	3.13e-05	0.000125	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ERBB2—stomach cancer	3.12e-05	0.000125	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ERBB2—stomach cancer	3.09e-05	0.000124	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL8—stomach cancer	2.97e-05	0.000119	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL8—stomach cancer	2.96e-05	0.000119	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HRAS—stomach cancer	2.95e-05	0.000118	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HRAS—stomach cancer	2.94e-05	0.000118	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL8—stomach cancer	2.93e-05	0.000117	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HRAS—stomach cancer	2.91e-05	0.000117	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	2.9e-05	0.000116	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—stomach cancer	2.9e-05	0.000116	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	2.89e-05	0.000116	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	2.86e-05	0.000115	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—stomach cancer	2.83e-05	0.000113	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—stomach cancer	2.82e-05	0.000113	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—stomach cancer	2.79e-05	0.000112	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCND1—stomach cancer	2.77e-05	0.000111	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—JUN—stomach cancer	2.76e-05	0.000111	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCND1—stomach cancer	2.76e-05	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—JUN—stomach cancer	2.75e-05	0.00011	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCND1—stomach cancer	2.73e-05	0.000109	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—JUN—stomach cancer	2.73e-05	0.000109	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—stomach cancer	2.69e-05	0.000108	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—stomach cancer	2.68e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	2.68e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	2.67e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—stomach cancer	2.65e-05	0.000106	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	2.64e-05	0.000106	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK8—stomach cancer	2.61e-05	0.000105	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK8—stomach cancer	2.61e-05	0.000104	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK8—stomach cancer	2.58e-05	0.000103	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—stomach cancer	2.41e-05	9.66e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—stomach cancer	2.41e-05	9.63e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—STAT3—stomach cancer	2.39e-05	9.56e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—stomach cancer	2.38e-05	9.53e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—STAT3—stomach cancer	2.38e-05	9.53e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—STAT3—stomach cancer	2.36e-05	9.44e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK3—stomach cancer	2.28e-05	9.14e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK3—stomach cancer	2.28e-05	9.11e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK3—stomach cancer	2.25e-05	9.02e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CA—stomach cancer	2.25e-05	8.99e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MYC—stomach cancer	2.22e-05	8.89e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MYC—stomach cancer	2.21e-05	8.86e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MYC—stomach cancer	2.19e-05	8.77e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK1—stomach cancer	2.17e-05	8.69e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EGFR—stomach cancer	2.17e-05	8.69e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK1—stomach cancer	2.17e-05	8.67e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EGFR—stomach cancer	2.17e-05	8.66e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK1—stomach cancer	2.14e-05	8.58e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EGFR—stomach cancer	2.14e-05	8.58e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KRAS—stomach cancer	2.05e-05	8.21e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KRAS—stomach cancer	2.05e-05	8.18e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KRAS—stomach cancer	2.03e-05	8.1e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.89e-05	7.54e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.88e-05	7.52e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.86e-05	7.45e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TP53—stomach cancer	1.82e-05	7.3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TP53—stomach cancer	1.82e-05	7.27e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TP53—stomach cancer	1.8e-05	7.2e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CA—stomach cancer	1.79e-05	7.14e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.74e-05	6.98e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HRAS—stomach cancer	1.74e-05	6.96e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.72e-05	6.89e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—stomach cancer	1.67e-05	6.68e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—stomach cancer	1.66e-05	6.66e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—stomach cancer	1.65e-05	6.59e-05	CbGpPWpGaD
